![Anup Soans Profile](https://pbs.twimg.com/profile_images/915276625872273408/-SxS6HeW_x96.jpg)
Anup Soans
@anupsoans
Followers
11K
Following
80K
Statuses
45K
MedicinMan - Amplifying Healthcare Voices
Bangalore
Joined August 2008
Indian Pharma Market Competitor Analysis โ Jan 2025 ......................................................................... Companies having the highest market share, strong brand portfolios, and consistent growth: ๐ A. Abbott (4 brands in the top 20) โ
Strengths: โข Domination in Anti-Diabetics (Ryzodeg, Mixtard) and Gastro-Intestinal (Udiliv) โข Highest growth rate in key brands (Ryzodeg โ 32.6%, Udiliv โ 25.5%) โข Strong distribution and doctor preference for insulin & hormone therapies โ Weaknesses: โข Mixtard shows signs of stagnation (-0.5% growth), losing ground to Ryzodeg. โข Not a leader in cardiac or respiratory therapies. ๐น Competitor Threats: โข USV and Glenmark are emerging in cardiac and anti-diabetics. โข Alkem is competing strongly in gastro-intestinal (Pan, Clavam). ๐ B. Cipla (3 brands in the top 20) โ
Strengths: โข Leader in Respiratory (Foracort, Duolin, Budecort). โข Strong brand equity and widespread doctor prescriptions. โ Weaknesses: โข Foracort (-0.4%) and Duolin (0.9%) are stagnating. โข Competition from Glenmark & USV in cardiac and Alkem in gastrointestinal. ๐น Competitor Threats: โข Glenmarkโs Telma is taking market share in the cardiac segment. โข Alkem and Abbott are growing faster in gastrointestinal and anti-diabetics. ๐ย C. Alkem (3 brands in the top 20) โ
Strengths: โข Fastest-growing in anti-infectives & gastro-intestinal (Clavam, Pan, Pan D). โข Pan D (15.4%) and Clavam (15.2%) are among the top-growing brands. โ Weaknesses: โข Limited presence in anti-diabetics and cardiac, where Abbott & USV are strong. โข Not a major player in respiratory therapies. ๐น Competitor Threats: โข Abbott dominates the gastrointestinal space with Udiliv. โข USV and Glenmark are stronger in the cardiac and anti-diabetic segments. ๐ย D. USV (2 brands in the top 20) โ
Strengths: โข Strong in anti-diabetics (Glycomet GP) and cardiac (Ecosprin AV). โข Ecosprin AV growing at 15.8%, competing with Glenmarkโs Telma. โ Weaknesses: โข No presence in gastrointestinal or anti-infectives. โข Glycomet GP (0.7% growth) is stagnating, facing competition from Ryzodeg. ๐นย Competitor Threats: โข Abbott is much stronger in anti-diabetics (Ryzodeg, Mixtard). โข Glenmark is becoming aggressive in the cardiac space. Read Time: 4 minutes. For More, Click - #pharma
0
1
1
Where have all these beauties gone? Citroen DS 21 Pallas sedan - 1955 to 1975 ................................................................... @Maruti_Corp is the worst offender in design, followed by @HondaCarIndia Or is it that Indians have lost their sense of aesthetics to make a Tiffinbox like WagonR a bestseller? Zen was a class act, and so was Esteem and the Honda 1st edition. Why even the Fiat and Amby were beauties. Name your best and worst auto design...
0
0
0
Hope this will lead to improvements ๐ @BLRAirport @CSMIA_Official
A question to anyone who understands airport security. A common phenomenon in Indian airports is that one is asked for the boarding card at the boarding gate, and then again 30 seconds later at the aircraft gate. At the latter, some number is manually struck off a chart. What exactly is the point of this, especially with aero bridge boarding ? I have never seen this in any other country. Is this a candidate for process reform?
0
0
0
โ๏ธ๐ฉบ๐ฅ๐ Without parent's support, therapy cannot go on for children.
Special gift from a little one. After 6 months of no speaking during play therapy sessions, she recently started communicating and yesterday got this for me. Without parent's support, therapy cannot go on for children. Her father was my patient when he was a kid. That helped.
0
0
1
๐๐ง๐ค๐ณ๐คฆโโ๏ธโ๏ธ๐ฉบ๐ฅ
Ah! The one sector that was left? Now in healthcare or rather in private for-profit health sector? After entering medical education first by taking over General Hospital of Bhuj in PPP-mode, where cost of MBBS course for management quota is ~Rs one crore, govt quota= ~40 lakh
0
0
1
Becoming great is a personal choice โ some root for excellence others are content with mediocrity ๐โ๏ธ๐ฉบ๐ฅ
Some private hospitals make good doctors! Some government medical colleges produce crappy ones ๐คท๐ฝโโ๏ธ Itโs time to move beyond this divide! #MedTwitter ๐ฎ๐ณ
0
0
1
๐๐ฏ๐ฏ
Hey @BeerBicepsGuy ๐๐ฝ Your podcast has always been garbage. Unfortunately, your audienceโs average IQ is below 70, so you'll never run out of fools to buy into your nonsense. The country will forget by tomorrow and start loving you again by Feb 13 ๐คท๐ฝโโ๏ธ
0
1
1